Antares Pharma Inc Drug Patent Portfolio
Antares Pharma Inc owns 1 orange book drug protected by 26 US patents Given below is the list of Antares Pharma Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10646495 | Testosterone ester triglyceride formulations | 30 Aug, 2038 | Active |
| US9950125 | Needle assisted jet injection administration of testosterone compositions | 04 Sep, 2036 | Active |
| US9744302 | Needle assisted jet injection device having reduced trigger force | 19 Nov, 2035 | Active |
| US11191908 | Syringe shock absorber for use in an injection device | 18 Oct, 2035 | Active |
| US11813435 | Needle assisted injection device having reduced trigger force | 25 Feb, 2035 | Active |
| US10238662 | Needle assisted jet injection administration of testosterone compositions | 19 Feb, 2035 | Active |
| US10912782 | Needle assisted injection administration of testosterone compositions | 19 Feb, 2035 | Active |
| US11160751 | Hematocrit modulation through needle assisted jet injection of testosterone | 07 Oct, 2034 | Active |
| US11771646 | Needle assisted jet injection administration of testosterone compositions | 10 Apr, 2034 | Active |
| US10881798 | Needle assisted injection device having reduced trigger force | 11 Feb, 2034 | Active |
| US10821072 | Needle assisted jet injection administration of testosterone compositions | 04 Jun, 2033 | Active |
| US11844804 | Administration of testosterone compositions | 04 Jun, 2033 | Active |
| US10357609 | Needle assisted jet injection device having reduced trigger force | 21 Aug, 2031 | Active |
| US10905827 | Injection device with cammed ram assembly | 21 Aug, 2031 | Active |
| US11446440 | Needle assisted injection device having reduced trigger force | 21 Aug, 2031 | Active |
| US10279131 | Injection device with cammed RAM assembly | 31 Jul, 2031 | Active |
| US11497753 | Hazardous agent injection system | 19 Mar, 2030 | Active |
| US8021335 | Prefilled syringe jet injector | 04 Oct, 2026 | Active |
| US10478560 | Prefilled syringe injector | 24 Jan, 2026 | Active |
| US11446441 | Prefilled syringe injector | 24 Jan, 2026 | Active |
| US8562564 | Prefilled syringe jet injector | 24 Jan, 2026 | Active |
| US9180259 | Prefilled syringe jet injector | 24 Jan, 2026 | Active |
| US9533102 | Prefilled syringe jet injector | 24 Jan, 2026 | Active |
| US9629959 | Prefilled syringe jet injector | 24 Jan, 2026 | Active |
| USRE44846 | Needle assisted jet injector | 10 Aug, 2019 | Expired |
| USRE44847 | Needle assisted jet injector | 10 Aug, 2019 | Expired |
Latest Legal Activities on Antares Pharma Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Antares Pharma Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 01 Jul, 2024 | US10881798 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 01 May, 2024 | US10821072 |
|
Email Notification
Critical
| 20 Dec, 2023 | US11844804 |
| Recordation of Patent eGrant | 19 Dec, 2023 | US11844804 |
|
Recordation of Patent Grant Mailed
Critical
| 19 Dec, 2023 | US11844804 |
| Mail Patent eGrant Notification | 19 Dec, 2023 | US11844804 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 19 Dec, 2023 | US11844804 |
| Patent eGrant Notification | 19 Dec, 2023 | US11844804 |
|
Email Notification
Critical
| 30 Nov, 2023 | US11844804 |
|
Issue Notification Mailed
Critical
| 29 Nov, 2023 | US11844804 |
| Recordation of Patent eGrant | 14 Nov, 2023 | US11813435 |
|
Recordation of Patent Grant Mailed
Critical
| 14 Nov, 2023 | US11813435 |
| Patent eGrant Notification | 14 Nov, 2023 | US11813435 |
|
Email Notification
Critical
| 14 Nov, 2023 | US11813435 |
| Mail Patent eGrant Notification | 14 Nov, 2023 | US11813435 |
Antares Pharma Inc Drug Patents' Oppositions Filed in EPO
Antares Pharma Inc drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Oct 07, 2019, by Bandpay & Greuter. This opposition was filed on patent number EP06719329A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP19150366A | Sep, 2022 | Bandpay & Greuter | Granted and Under Opposition |
| EP06719329A | Oct, 2019 | Bandpay & Greuter | Patent maintained as amended |
Antares Pharma Inc's Family Patents
Antares Pharma Inc drugs have patent protection in a total of 13 countries. It has a significant patent presence in the US with 56.2% of its patents being US patents. 4 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Antares Pharma Inc Drug List
Given below is the complete list of Antares Pharma Inc's drugs and the patents protecting them.
1. Xyosted (autoinjector)
Xyosted (autoinjector) is protected by 26 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10646495 | Testosterone ester triglyceride formulations |
30 Aug, 2038
(13 years from now)
| Active |
| US9950125 | Needle assisted jet injection administration of testosterone compositions |
04 Sep, 2036
(11 years from now)
| Active |
| US9744302 | Needle assisted jet injection device having reduced trigger force |
19 Nov, 2035
(11 years from now)
| Active |
| US11191908 | Syringe shock absorber for use in an injection device |
18 Oct, 2035
(10 years from now)
| Active |
| US11813435 | Needle assisted injection device having reduced trigger force |
25 Feb, 2035
(10 years from now)
| Active |
| US10238662 | Needle assisted jet injection administration of testosterone compositions |
19 Feb, 2035
(10 years from now)
| Active |
| US10912782 | Needle assisted injection administration of testosterone compositions |
19 Feb, 2035
(10 years from now)
| Active |
| US11160751 | Hematocrit modulation through needle assisted jet injection of testosterone |
07 Oct, 2034
(9 years from now)
| Active |
| US11771646 | Needle assisted jet injection administration of testosterone compositions |
10 Apr, 2034
(9 years from now)
| Active |
| US10881798 | Needle assisted injection device having reduced trigger force |
11 Feb, 2034
(9 years from now)
| Active |
| US10821072 | Needle assisted jet injection administration of testosterone compositions |
04 Jun, 2033
(8 years from now)
| Active |
| US11844804 | Administration of testosterone compositions |
04 Jun, 2033
(8 years from now)
| Active |
| US10357609 | Needle assisted jet injection device having reduced trigger force |
21 Aug, 2031
(6 years from now)
| Active |
| US10905827 | Injection device with cammed ram assembly |
21 Aug, 2031
(6 years from now)
| Active |
| US11446440 | Needle assisted injection device having reduced trigger force |
21 Aug, 2031
(6 years from now)
| Active |
| US10279131 | Injection device with cammed RAM assembly |
31 Jul, 2031
(6 years from now)
| Active |
| US11497753 | Hazardous agent injection system |
19 Mar, 2030
(5 years from now)
| Active |
| US8021335 | Prefilled syringe jet injector |
04 Oct, 2026
(1 year, 10 months from now)
| Active |
| US10478560 | Prefilled syringe injector |
24 Jan, 2026
(1 year, 2 months from now)
| Active |
| US11446441 | Prefilled syringe injector |
24 Jan, 2026
(1 year, 2 months from now)
| Active |
| US8562564 | Prefilled syringe jet injector |
24 Jan, 2026
(1 year, 2 months from now)
| Active |
| US9180259 | Prefilled syringe jet injector |
24 Jan, 2026
(1 year, 2 months from now)
| Active |
| US9533102 | Prefilled syringe jet injector |
24 Jan, 2026
(1 year, 2 months from now)
| Active |
| US9629959 | Prefilled syringe jet injector |
24 Jan, 2026
(1 year, 2 months from now)
| Active |
| USRE44846 | Needle assisted jet injector |
10 Aug, 2019
(5 years ago)
| Expired |
| USRE44847 | Needle assisted jet injector |
10 Aug, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xyosted (autoinjector)'s drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List